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1  | INTRODUC TION
According to the recommendations of the World Health Organization 
(WHO), analysis of semen is the basis of diagnosis and evaluation of 
male fertility (Cooper et al., 2010).
Infertility is defined as the inability to conceive after 12 months of 
regular and unprotected intercourse by a healthy couple (Skakkebæk 
et al., 2006).
However, the limits of semen study have been more broadened 
by investigations demonstrating that 15% of men, considered nor‐
mal according to the WHO 2010 guidelines, are infertile and other 
men with aberrant sperm parameters are concerned their spouses 
might become pregnant naturally (Agarwal & Prabakaran, 2005; 
Nallella, Sharma, Aziz, & Agarwal, 2006).
It is therefore insufficient to evaluate and predict male fertil‐
ity potential, based primarily on routine semen analysis, assessing 
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Abstract
The aim of this study was to evaluate the relationship between the protamine ratio 
(P1/P2), DNA fragmentation of spermatozoa and protamine deficiency. Patients were 
grouped into fertile (G1; n = 151) and sub‐fertile (G2; n = 121). DNA fragmentation in 
spermatozoa was analysed by a TUNEL assay (terminal deoxynucleotidyl transferase‐
mediated deoxyuridine triphosphate nick‐end labelling), and the protamination was de‐
termined by CMA3 staining, while Western blot was used to measure protamine P1 and 
P2. While sperm DNA fragmentation (SDF) and protamine ratio were significantly ele‐
vated in G2 compared with G1 (12.31 ± 7.01% vs. 17.5 ± 9.5%; p = .001) and (0.91 ± 0.43 
vs. 0.75 ± 0.42; p = .003); respectively, the CMA3 positive showed no difference at all 
between G1 and G2. In G1, the CMA3 positive correlated negatively with the P1/P2 
ratio and SDF (r	=	−.586,	r	=	−.297;	p = .001 respectively). In contrast, the protamine ratio 
correlated positively with SDF (r = .356; p = .001). In G2, no correlation was observed 
between CMA3 positive, SDF and the P1/P2 ratio but the P1/P2 ratio showed a posi‐
tive correlation with SDF (r = .479; p = .001). In conclusion, the spermatozoa DNA deteri‐
oration was closely associated with abnormal protamination but showed an association 
with the protamine ratio, more than with CMA3 positive. Therefore, for the evaluation 
of DNA damage in spermatozoa, the P1/P2 ratio might act as an additional biomarker.
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sperm count, motility and morphology (WHO, 2010). Consequently, 
science is now shifting towards analysing the molecular aspects of 
spermatozoa.
The role of spermatozoa is to deliver the paternal genetic infor‐
mation to the oocyte containing the maternal genetic information. 
Before this can occur, a remarkable arrangement takes place during 
the post‐meiotic phases of spermatogenesis (Rathke, Baarends, 
Awe, & Renkawitz‐Pohl, 2014).
Spermatids go through major morphological changes, involv‐
ing specific chromatin compaction and reorganisation. As a result, 
the structure of the nucleosome, based on the histones, is almost 
completely changed in structure due to protamine. Histone vari‐
ants, namely post‐translational adjustment of histones, mediate this 
change and effect breaks in and rearrangements of DNA strands 
(Rathke et al., 2014).
Therefore, during the process of the chromatin remodelling of 
spermatozoa, many anomalies may occur in each step, especially at 
the level of the organisation of the DNA, during histone–protamine 
exchange and disulphide bond formation. However, the sperm chro‐
matin conformation and the DNA integrity are both important for 
fecundity (Sakkas, Seli, Bizzaro, Tarozzi, & Manicardi, 2003; Spano, 
Seli, Bizzaro, Manicardi, & Sakkas, 2005) and fertility (Spano et al., 
2005). In addition, the sperm DNA plays a crucial role in the conser‐
vation of the genetic information for future offspring.
For the last two decades, sperm chromatin aberration has 
been widely studied (Agarwal & Said, 2003). Anomalies in sper‐
matozoa's chromatin structure, damaged DNA and unremodelled 
chromatin of maturing sperm could be indicators of infertility in 
humans, regardless of the value of the other settings of the nor‐
mal semen parameters (Sakkas & Tomlinson, 2000). Moreover, the 
sperm quality of the chromatin is in correlation to the gestation 
outcomes of in vitro fertilisation (IVF; Duran, Morshedi, Taylor, & 
Oehninger, 2002; Hammadeh, Strehler, Zeginiadou, Rosenbaum, 
& Schmidt, 2001).
In the last two decades, there have been attempts to suggest 
other methods for exploring sperm DNA stability and integrity in 
order to overcome fertility problems and to ameliorate the semen 
parameter analysis for procreation in vitro and in vivo.
It is now obvious that there is a close association between im‐
paired spermiogenesis and sperm DNA damage, causing aberrant 
chromatin remodelling. Aitken and De Iuliis (2011) proposed that 
the latter was linked to the creation of vulnerable spermatozoa that 
readily default to an apoptotic pathway, recognised by the genera‐
tion by reactive oxygen species (ROS) by mitochondria and the cre‐
ation of oxidative DNA adducts, leading to the formation of strand 
breaks. Oxidative stress is accordingly regarded as the main cause of 
sperm DNA damage. Increased ROS production has been associated 
mainly with the products of mitochondrial respiration (cellular me‐
tabolism). In fact, mitochondria are believed to be the first targets of 
oxidative damage. ROS can also be produced in response to differ‐
ent environmental and lifestyle factors (Cui, Kong, & Zhang, 2012).
Smoking has been shown to negatively affect semen qual‐
ity and to increase sperm DNA fragmentation (SDF) and 
aberrant protamination (Hammadeh, Hamad, Montenarh, & 
Fischer‐Hammadeh, 2010; Taha, Ez‐Aldin, Sayed, Ghandour, & 
Mostafa, 2012). Gundersen et al. (2015) found that marijuana use 
of more than one time per week reduced sperm concentration by 
28%.
Firns et al. (2015) showed that alcohol consumption reduces 
semen volume, sperm concentration, motility and morphology. 
However, the claim that semen quality is likely to be influenced by 
how frequently people drink remains a controversial issue.
Diets rich in soya have a negative effect on sperm concentration; 
this could be explained by the high levels of isoflavones in soya that 
may	disrupt	hormone	levels	(Chavarro,	Toth,	Sadio,	&	Hauser,	2008).
Obesity is related to the development of metabolic syndrome, 
which has been shown to have a deleterious effect on the sperm pa‐
rameters (Gorbachinsky, Akpinar, & Assimos, 2010; Kasturi, Tannir, 
&	Brannigan,	2008).
In addition, different studies have examined the correlation 
between increasing age and the semen parameters and found a 
decreasing volume, motility and morphology associated with an in‐
crease	in	DNA	fragmentation	(Belloc	et	al.,	2009;	Johnson,	Dunleavy,	
Gemmell, & Nakagawa, 2015; Vagnini et al., 2007).
Many techniques, such as aniline blue, CMA3 assay and TUNEL 
(Aoki, Emery, Liu, & Carrell, 2006; Hammadeh et al., 2010; Manicardi 
et al., 1995), have been used to detect a correlation between pro‐
tamine deficiency, alterations in DNA and the absence of sperm 
vitality. Lately, there have been a number of techniques, such as 
terminal deoxynucleotidyl transferase‐mediated dUDP nick‐end la‐
belling (TUNEL), a sperm chromatin structure assay (SCSA), a sperm 
chromatin dispersion (SCD) assay and a comet assay (Agarwal et al., 
2016) to evaluate DNA fragmentation.
However, most of the techniques used provide limited informa‐
tion about the nature of the DNA lesions evidenced and do not allow 
the exact pathogenesis of the disrupted sperm DNA to be high‐
lighted (Agarwal & Said, 2004; Bungum, 2012).
Less expensive methods to assess the sperm chromatin struc‐
ture use chromatin structural probes or dyes. For example, acri‐
dine orange is used to measure the susceptibility to conformational 
changes and toluidine blue is used to stain phosphate residues of 
fragmented DNA. There are also two indirect staining agents that 
are simple and provide results describing the general deficits in the 
sperm chromatin; aniline blue (AB) is used to stain selectively ly‐
sine‐rich histone proteins, thereby revealing the loosely condensed 
chromatin (Auger, Mesbah, Huber, & Dadoune, 1990; Hammadeh 
et al., 2001), and chromomycin A3 is a guanine‐cytosine‐specific 
fluorochrome that competes with protamine for binding to specific 
regions (minor grooves) in DNA, revealing protamination defects in 
spermatozoa (Bianchi, Manicardi, Bizzaro, Bianchi, & Sakkas, 1993; 
Sakkas et al., 1996).
Although a DNA integrity test provides complementary infor‐
mation about the sperm's role in the pregnancy development, but 
up until now, there has been no approval to utilise DNA integrity 
tests in reproduction laboratories' routine work (Bach & Schlegel, 
2016).
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The aims of the current study were first to discover the prota‐
mine deficiency in spermatozoa and to assess spermatozoa's DNA 
injury and, second, to quantify the concentration of protamines (P1 
and P2) and their ratio (P1/P2 ratio) and to find out whether these 
investigated parameters correlated with standard sperm parameters 
in order to reveal whether the P1/P2 ratio can be applied as a bio‐
marker for the evaluation of sperm function and their fertilisation 
potential in fertile and sub‐fertile patients undergoing ICSI therapy.
2  | MATERIAL S AND METHODS
2.1 | Study population
In the present study, 272 sperm samples were gathered from pa‐
tients undergoing IVF/ICSI therapy at the Department of Obstetrics, 
Gynaecology and Reproductive Medicine, Women's Clinic, Saarland, 
Germany.
The exclusion criteria for patients in this study were the follow‐
ing: diabetes, alcohol consumption, testes injury, the existence of 
anti‐sperm antibodies, genital tract infection, varicocele, chronic 
male diseases such as tuberculosis and genetic disorders such as 
Klinefelter's syndrome, Y chromosome micro‐deletions and hor‐
monal disorders. In addition, patients who had been exposed to 
environmental factors, such as toxins, chemicals and heat, were ex‐
cluded too.
All the participants included in this study were of reproductive 
age, the range being between 25 and 50 years old.
After semen collection and liquification at 37 degrees for 
20–30 min, the sperm parameters of each sample were analysed ac‐
cording to WHO (2010) guidelines. Five smears were taken from each 
sample for later use in chromomycin (CMA3), TUNEL test and sperm 
morphology evaluation. For chromomycin (CMA3), smears were air‐
dried and fixed with methanol and acetic acid (3:1 volume|volume).
For sperm morphology, slides were stained with papanicolaou, 
and then, 100 spermatozoa were evaluated.
Samples were prepared for insemination or injection, using the 
Pure Sperm technique (Nidacon International AB). The rest of the 
sperm	was	kept	for	later	at	−80°C.
2.2 | Sperm chromatin condensation assay 
(chromomycin A3 [CMA3])
A chromomycin A3 assay, as described by Manicardi et al. (1995) but 
with some changes, was used for the sperm chromatin condensation 
assessment.
Chromomycin is a fluorochrome that binds to the guanine‐cyto‐
sine dinucleotide region of the DNA in a competitive way with pro‐
tamines binding to the same region, so that spermatozoa having an 
elevated concentration of protamine will theoretically have a small 
amount of chromomycin fluorescence (Bianchi et al., 1993).
To each slide, 25 µl of CMA3 stain solution was added and the 
slide	 then	 kept	 in	 darkness	 for	 30	min	 at	 25°C.	After	 the	 slides	
had been washed with phosphate buffer saline (PBS), they were 
mounted	 and	 preserved	 overnight	 at	 4°C.	 On	 each	 slide,	 200	
spermatozoa were evaluated using a fluorescence microscope 
(Olympus). A bright green spermatozoon indicated protamine de‐
ficiency (CMA3 positive), and dull green spermatozoa were CMA3 
negative (Figure 1).
2.3 | Sperm DNA fragmentation assessment 
(terminal deoxynucleotidyl transferase‐mediated 
dUTP nick‐end labelling [TUNEL])
A TUNEL assay was used to determine the DNA injury in spermato‐
zoa, as previously described by Borini et al. (2006).
The principal aim of the assay test is to quantify the incorpo‐
ration of dUTP at single‐ and double‐stranded DNA breaks, cata‐
lysed by the terminal deoxynucleotidyl transferase (TdT) enzyme, 
provided in the in situ cell death detection kit fluorescein (Roche 
Diagnostics).
After smear fixation with 4% paraformaldehyde (Sigma‐Aldrich) 
for	2	hr	at	25°C,	the	slides	were	incubated	with	0.1%	Triton	for	15	min	
at	25°C	for	permeabilisation.	To	each	slide,	25	μl of TdT‐labelled nu‐
cleotide mix was added, and the slides were then preserved over‐
night	at	37°C	in	a	humidified	chamber.	After	washing	the	slides	with	
PBS, 25 μl	of	4′,6‐diamidine‐2′‐phenylindole	dihydrochloride	(DAPI;	
Sigma‐Aldrich) was added to each slide. On each slide, 200 sperma‐
tozoa were evaluated, using a fluorescence microscope (Olympus): 
stained green spermatozoa were TUNEL‐positive but blue‐stained 
spermatozoa were TUNEL‐negative (Figure 2).
2.4 | Protamine extraction
Protamines (P1 and P2) were extracted from the stored sperm 
pellets, as described by Hammadeh et al. (2010). The pellets were 
cleaned with 1 ml of the washing solution 1 (1 mM of phenylmethyl‐
sulfonyl fluoride [PMSF]) and later put on centrifuge (250 g/5 min) at 
25°C.	Then,	100	μl of washing solution 2 (20 mM EDTA and PMSF 
F I G U R E  1   Illustrative human sperm cells stained with CMA3. 
Normal condensed sperm chromatin (CMA3 negative) fluorescent 
dull green (1), whereas noncondensed sperm chromatin (CMA3 
positive) fluorescent bright green (2) (GrX100)
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[1	mmol,	pH	8.0])	was	added	to	the	pellets	and	mixed	for	15	s	and	
100 μl of decondensation solution 1 (6 M guanidine hydrochloride 
and 575 dithiothreitols [DTT]) was included and mixed again for a 
few seconds.
Thereafter, 200 μl of decondensation solution 2 (522 mM sodium 
iodoacetate) was added, mixed for 30 s and incubated for half an 
hour at RT. After this step, 1 ml of absolute ethanol was included, 
mixed	and	preserved	for	1	min	at	−20°C.	The	mix	then	was	placed	
in a centrifuge (1,000 g/10	min)	at	4°C.	At	that	point,	0.8	ml	of	de‐
naturing solution (0.5 M HCl) was added to the pellet and preserved 
at	37°C	 (15	min).	This	preparation	was	then	placed	 in	a	centrifuge	
(1,000 g/10	min)	 at	 4°C.	 Supernatant	was	 exchanged	 to	 a	 second	
tube including 200 μl of precipitating buffer (100% trichloroacetic 
corrosive [TCA]) and incubated in ice for 3 min followed by a centrif‐
ugation (1,000 g/10	min)	at	4°C.	Finally,	the	precipitate	was	cleaned	
with 1 ml of washing solution (1% ß‐mercaptoethanol in 100% ace‐
tone) and mixed roughly for a few seconds. The mix was placed in a 
centrifuge (1,000 g/8	min)	at	4°C,	and	the	pellet	was	left	to	dry	at	
4°C	for	the	night	and	then	preserved	at	−80°C.
2.5 | Preparation of the human protamine 
standard and control samples
Sperm samples of 30 proven fertile men were mixed and centrifuged 
(250 g/10 min) at RT. Then, a PBS buffer was used to wash the pellet 
that was later placed in a centrifuge (250 g/10 min) at RT.
Next, a mixture of 0.5 ml of the denaturing solution (0.5 M 
HCL)	 and	 the	 pellets	 was	 preserved	 at	 37°C	 (15	min)	 and	 centri‐
fuged (250 g/5	min)	at	25°C.	The	pellets	were	kept	and	washed	with	
0.25 ml of washing solution 2 and re‐centrifuged, as before. After 
that, the same procedure for protamine extraction, as described 
before, was performed. The RC DC protein assay kit (Bio‐Rad) and 
the spectrophotometer (Ultrospec 2100 pro UV/Visible; Amersham 
Biosciences) were used for the evaluation of the protein concentra‐
tion. For calculation of the protamine 1 and 2 concentrations, four 
protamine standards (1.5, 1, 0.5 and 0.25 µg/µl) were used to draw 
a regression curve (R2	≥	.98)	for	each	run.
For control, 40 × 106	sperm	aliquots	were	stored	at	−80°C	and	
one aliquot was used for every run with the studied samples.
2.6 | Protamine quantification: Western blotting
The acetic acid‐urea polyacrylamide gel electrophoresis (AU‐PAGE) 
method, combined with the Western blot, was used for estimation 
of the extracted protamines.
Before the samples were loaded, the gel was electrophoresed 
(200 V, 25 mA/3 hr) with reverse polarity.
Eighty microliter of loading buffer (0.375 M potassium ace‐
tate, 15% sucrose and 0.05% methyl green [pH 4.0]) was added 
to previously extracted nuclear proteins, and then, 10 µl of each 
sample was loaded onto the gel with the control sample and then 
placed in a vertical home‐made gel electrophoresis system (200 V, 
25 mA/3 hr).
The proteins were removed to a PVDF membrane (Roche) 
by using a blotting tank with 0.0009 N acetic acid as a transfer 
buffer (150 mA/overnight). Later, the membranes were blocked 
in a blocking buffer (PBS, pH 7.4, 0.1% [v/v] Tween 20 and 5% 
[w/v] nonfat dry milk) for 1 hr at RT with shaking. The membranes 
were washed with a washing buffer (1× PBS, pH 7.4, 0.1% [v/v] 
Tween 20, 1% [w/v] nonfat dry milk) three times, each for 7 min 
with shaking at RT. The membranes were incubated with the pri‐
mary antibody diluted in the previously mentioned washing buf‐
fer	 (4°C/overnight)	with	 shaking.	One	membrane	was	 incubated	
with a Hup 1N (anti‐protamine 1)‐specific primary antibody, di‐
luted 1:100,000, and the second membrane was incubated with 
a Hup 2B (anti‐protamine 2)‐specific primary antibody, diluted 
1:500,000,	overnight	at	4°C.
Then, the membrane was washed and re‐preserved with the 
horseradish peroxidase‐conjugated goat anti‐mouse IgG antibody 
(Dianova) for 1 hr with shaking at RT.
The Lumi‐light chemiluminescence kit (Roche) and the enhanced 
chemiluminescence system (Bio‐Rad) were used to measure the in‐
tensity of the protamine bands.
The standard curve was used to calculate the protamine con‐
centrations for each sample. The P1/P2 ratio was generated using 
the image analysis software as follows: (P1 band‐background)/(P2 
band‐background).
2.7 | Statistical analysis
The data were analysed at the Institute of Medical Biometry and 
Medical Information, Saarland University, Germany, using the 
Windows Software SPSS 24 (SPSS Inc.).
Based on the Shapiro test, z‐value kurtosis and skewer tests, 
studied samples were nonnormally distributed.
A Mann–Whitney test was used to compare the means of quan‐
titative variables and the different correlations that had been ex‐
pressed, according to the Spearman correlation test.
F I G U R E  2   Illustrative human sperm cells stained with TUNEL 
(DAPI). TUNEL‐negative sperm stain blue (1) and TUNEL‐positive 
sperm stain green (2) (GrX40)
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3  | RESULTS
The semen samples included in the present study were divided into 
fertile (n = 151) and sub‐fertile groups (n = 121).
Patients who had one child or more and had normal semen pa‐
rameters (volume: 1.5 ml, sperm count: 15 million spermatozoa/ml; 
normal	forms:	4%;	vitality:	58%	live;	progressive	motility:	32%;	total	
[progressive + non progressive] motility: 40%, according to WHO 
guidelines 2010) were considered as a fertile group, and those who 
had failed to have children and had one sperm parameters under 
WHO (2010) criteria were considered as a sub‐fertile group.
3.1 | The different parameters in the set of 
studied subjects
All parameters measured in the present study have been expressed 
in mean ± standard deviation and are presented in Table 1. The 
sperm	parameter	values	were	64.81	±	39.66	×	106/ml for concentra‐
tion,	35.90	±	18.64%	progressive	motility,	and	the	normal	morphol‐
ogy was 29.65 ± 23.46%.
Protamine deficiency was measured by CMA3 staining, and 
sperm DNA fragmentation (SDF) evaluated via a TUNEL test was 
34.30	±	15.97%	and	14.60	±	8.58%	respectively.
P1 concentration was 432.35 ± 124.14 (ng/106 spermatozoa), P2 
concentration	was	397.85	±	125.19	 (ng/106 spermatozoa), and the 
protamine	ratio	was	0.83	±	0.49.
The various correlations are presented in Table 2a. A significant 
negative correlation between age and these investigated parameters 
was found as follows: sperm count (r	=	−.144;	p	=	.018),	progressive	
motility (r	=	−.129;	p = .034) and normal morphologically spermato‐
zoa (r	=	−.248;	p = .001). Besides, CMA3 positive (protamine defi‐
ciency) increased with the increasing age of patients.
Moreover, a correlation was noticed between age and SDF 
(r = .199; p = .001). Similarly, a positive correlation was observed be‐
tween the age of patients and the protamine ratio (r = .234; p = .001) 
that had been registered.
In addition, the concentration of spermatozoa correlated neg‐
atively with SDF (r	 =	 −.20;	 p = .001), CMA3 positive (r	 =	 −.172;	
p = .005) and (P1/P2) ratio (r	=	−.208;	p = .001) but correlated posi‐
tively with morphologically normal spermatozoa (r = .261; p = .007) 
and with the progressive motility (r = .342; p = .0001).
In contrast to the age and the concentration, the progressive 
motility correlated positively with protamine 1 (r = .171; p = .05) 
and protamine 2 (r = .239; p = .001) but negatively with the SDF 
(r	=	−.334;	p = .001).
In addition, the mean percentage of normal morphology sperma‐
tozoa demonstrated a significant positive correlation with the CMA3 
positive (r = .216; p = .001) but correlated negatively (p < .01) with 
protamine 1, protamine 2 and protamine ratio (r	=	−.271;	r	=	−.259;	
r	=	−.323	respectively).
Sperm DNA fragmentation presented a highly significant pos‐
itive correlation with the protamine ratio (r = .433; p = .001) and 
negative, insignificant correlations with protamine 1 and protamine 
2 and the CMA3 positive (r	=	−.022;	r	=	−.102;	r	=	−.093	respectively;	
Table 2b).
CMA3 positive was negatively correlated with protamine 1 
(r	=	−.154;	p = .011) and with the protamine ratio (r	=	−.349;	p = .001; 
Table 2b).
Protamines 1 and 2 showed a positive correlation (r = .796; 
p = .001). The protamine ratio correlated positively with P1 (r = .269; 
p = .001), unlike P2 (Table 2b).
3.2 | Comparison between fertile and sub‐
fertile patients
By comparing the sperm parameters, expressed as the 
mean ± standard deviation (Table 1), between the two groups of 
fertile and sub‐fertile men, it was found that there was no signifi‐
cant difference regarding sperm morphology and the CMA3 posi‐
tive despite the two parameters being lower in the men who were 
sub‐fertile.
The age and protamine ratio (P1/P2) were higher in the sub‐
fertile group (p < .01), and the other parameters were lower 
(Table 1).
In the fertile group, the correlations between CMA3 positive, 
SDF and protamines P1, P2 and their ratio are listed in Table 3.
TA B L E  1   Comparison of studied parameters between fertile and sub‐fertile groups
Parameters All patients (n = 272; M ± SD) Fertile (n = 151; M ± SD) Sub‐fertile (n = 121; M ± SD) p‐value
Sperm concentration (×106 spz/ml) 64.81	±	39.66 78.45	±	38.84 47.90	±	33.85 .001** 
Progressive motility (%) 35.90	±	18.64 47.39 ± 15.04 21.56 ± 11.32 .001** 
Morphologically normal spermatozoa (%) 29.65 ± 23.46 31.36 ± 22.06 27.52 ± 25.01 .180
Sperm DNA fragmentation (SDF; %) 14.60	±	8.58 12.31 ± 7.01 17.50 ± 9.50 .001** 
Protamine deficiency (CMA3 positive; %) 34.30 ± 15.97 32.94 ± 15.12 35.99	±	16.89 .118
Protamine 1 (ng/106 spz) 432.35 ± 124.14 447.29	±	120.85 413.69 ± 126.15 .026* 
Protamine 2 (ng/106 spz) 397.85	±	125.19 416.90 ± 120.14 374.08	±	127.77 .005** 
P1/P2 ratio 0.83	±	0.49 0.75 ± 0.42 0.91 ± 0.43 .003** 
Abbreviations: M, mean; SD, standard deviation; Spz, spermatozoa.
*Correlation is significant at the .05 level. 
**Correlation is significant at the .01 level. 
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Sperm DNA fragmentation correlated negatively with the CMA3 
value (r	=	−.297;	p = .001) and protamine ratio (P1/P2; r = .356; p = .001).
In turn, the value of CMA3 is negatively correlated (p < .01) with 
protamines P1, P2 (r	=	−.249,	r	=	−.212	respectively)	and	their	ratio	
(r	=	−.586;	p = .001).
P1 had a highly significant correlation with P2 (r	=	.857;	p = .001) 
and the P1/P2 ratio (r = .329; p = .001). The P1/P2 ratio had a sig‐
nificant positive correlation with the protamine 2 (r = .176; p = .031).
In the sub‐fertile group, the CMA3 positive showed no correlations 
to SDF and protamines P1, P2 and their ratio (Table 4). SDF had a highly 
positive correlation with the protamine ratio (P1/P2; r = .479; p = .001).
Protamine 1 correlated highly positive with protamine 2 (r = .720; 
p = .001) and with the protamine ratio (P1/P2; r = .255; p = .005; 
Table 4).
3.3 | Comparison between the measured 
parameters in all patients according to the CMA3 
test results
The sperm DNA protamination (DNA condensation) was measured 
by the chromomycin (CMA3) staining technique. According to the 
results from this test, the patients were divided into two groups, 
TA B L E  2   (a) Correlations between various parameters for all investigated patients (N = 272). (b) Correlations between different measured 
parameters for all patients (N = 272)
(a)
 Age (Year) Concentration (×106/ml) Progressive motility (%) Normal morphology (%)
Age (year)  r	=	−.144*  r	=	−.129*  r	=	−.248** 
– p	=	.018 p = .034 p = .001
Sperm concentration (×106 
spz/ml)
r	=	−.144*   r = .342**  r = .164** 
p	=	.018 – p = .001 p = .007
Progressive motility (%) r	=	−.129*  r = .342**   r	=	−.095
p = .034 p = .001 – p = .120
Morphologically normal sper‐
matozoa (%)
r	=	−.248**  r = .164**  r	=	−.095  
p = .001 p = .007 p = .120 –
Sperm DNA fragmentation 
index SDF (%)
r = .199**  r	=	−.201**  r	=	−.334**  r	=	−.048
p = .001 p = .001 p = .001 p = .432
Protamine deficiency (CMA3 
positive; %)
r	=	−.198**  r	=	−.172**  r	=	−.110 r = .216** 
p = .001 p = .005 p = .071 p = .001
Protamine 1 (ng/106 spz) r	=	.078 r = .117 r = .171**  r	=	−.271** 
p = .202 p = .054 p = .005 p = .001
Protamine 2 (ng/106 spz) r = .022 r = .104 r = .239**  r	=	−.259** 
p = .716 p	=	.087 p = .001 p = .001
(P1/P2)ratio r = .234**  r	=	−.208**  r	=	−.008 r	=	−.323** 
p = .001 p = .001 p	=	.894 p = .001
(b)
 DFI (%) CMA3 positive (%) Protamine 1 (ng/106 spz) Protamine 2 (ng/106 spz) P1/P2 ratio
Sperm DNA fragmentation 
(SDF; %)
 r	=	−.093 r =	−.022 r	=	−.102 r = .433** 
– p = .125 p = .723 p = .094 p = .001
Protamine deficiency (CMA3 
positive; %)
r	=	−.093  r	=	−.154*  r	=	−.081 r	=	−.349** 
p = .125 – p = .011 p	=	.184 p = .001
Protamine 1 (ng/106 sperm) r	=	−.022 r	=	−.154*   r = .796**  r = .269** 
p = .723 p = .011 – p = .001 p = .001
Protamine 2 (ng/106 sperm) r	=	−.102 r	=	−.081 r = .796**   r = .039
p = .094 p	=	.184 p = .001 – p = .524
P1/P2 ratio r = .433**  r	=	−.349**  r = .269**  r = .039  
p = .001 p = .001 p = .001 p = .524 –
Abbreviation: Spz, spermatozoa.
*Correlation is significant at the .05 level. 
**Correlation is significant at the .01 level. 
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according to the value of CMA3 positive, as defined by Zandemami 
et al. (2012).
•	 Group	of	condensed	chromatin	(CMA3	positive	≤31%,	n = 133)
• Group of noncondensed chromatin (CMA3 positive >31%, 
n = 139).
Table 5 illustrates the comparison of various studied parameters 
between the two investigated groups.
Progressive motility and protamine ratio were significantly lower 
in the group of noncondensed chromatin in comparison with the con‐
densed	chromatin	group	(33.01	±	16.90%	vs.	38.92	±	19.92%;	p = .009; 
0.66 ± 0.47 vs. 1.00 ± 0.32; p = .001 respectively), whereas the mor‐
phologically normal spermatozoa and the CMA3 value were higher 
among the noncondensed chromatin group in comparison with the 
group	of	condensed	chromatin	(35.46	±	24.83%	vs.	23.59	±	20.31%;	
p = .001; 46.36 ± 12.95% vs. 21.69 ± 5.96%; p = .0001).
3.4 | Comparison between the measured 
parameters among all patients according to the 
results of the TUNEL test
According to the sperm DNA fragmentation (SDF), defined by 
Chohan,	Griffin,	Lafromboise,	Jonge,	and	Carrell	(2006),	the	follow‐
ing three groups were formed:
•	 Group	with	nonfragmented	DNA	(SDF	≤	15%)
• Group with moderately fragmented DNA (16% < SDF < 30%)
•	 Group	with	fragmented	DNA	(SDF	≥	30%).
The age, the P1/P2 ratio and the SDF were significantly higher in 
the group with fragmented DNA (p = .001), whereas the concentra‐
tion, the progressive motility and the protamine 2 were significantly 
higher in the group with nonfragmented DNA (p = .002; p = .001 and 
p = .012 respectively; Table 6).
TA B L E  3   Correlations between DNA integrity parameters and protamine by fertile patients
 
Sperm DNA fragmen‐
tation (SDF; %)
Protamine deficiency 
(CMA3 positive; %)
Protamine 1 
(ng/106 spz)
Protamine 2 
(ng/106 spz) (P1/P2) ratio
Sperm DNA fragmentation 
(SDF; %)
 r	=	−.297**  r = .024 r	=	−.017 r = .356** 
– p = .001 p = .771 p	=	.834 p = .001
Protamine deficiency (CMA3 
positive; %)
r	=	−.297**   r	=	−.249**  r	=	−.212**  r	=	−.586** 
p = .001 – p = .002 p = .009 p = .001
Protamine 1 (ng/106 spz) r = .024 r	=	−.249**   r	=	.857**  r = .329** 
p = .771 p = .002 – p = .0001 p = .001
Protamine 2 (ng/106 spz) r	=	−.017 r	=	−.212**  r	=	.857**   r = .176* 
p	=	.834 p = .009 p = .001 – p = .031
P1/P2 ratio r = .356**  r	=	−.586**  r = .329**  r = .176*   
p = .001 p = .001 p = .0001 p = .031 –
Abbreviation: Spz, spermatozoa.
*Correlation is significant at the .05 level. 
**Correlation is significant at the .01 level. 
TA B L E  4   Correlations between DNA integrity parameters and protamine in sub‐fertile patients
 
Sperm DNA fragmenta‐
tion (SDF; %)
Protamine deficiency 
(CMA3 positive; %)
Protamine 1 
(ng/106 spz)
Protamine 2 
(ng/106 spz) (P1/P2) ratio
Sperm DNA fragmentation 
(SDF; %)
 r = .136 r	=	.028 r	=	−.083 r = .479** 
– p = .136 p = .757 p	=	.368 p = .001
Protamine deficiency (CMA3 
positive; %)
r = .136  r	=	.008 r = .090 r	=	−.057
p = .136 – p = .927 p = .327 p = .533
Protamine 1 (ng/106 spz) r	=	.028 r	=	.008  r = .720**  r = .255** 
p = .757 p = .927 – p = .001 p = .005
Protamine 2 (ng/106 spz) r	=	−.083 r = .090 r = .720**   r	=	−.072
p	=	.368 p = .327 p = .001 – p = .432
(P1/P2) ratio r = .479**  r	=	−.057 r = .255**  r	=	−.072  
p = .001 p = .533 p = .005 p = .432 –
Abbreviation: Spz, spermatozoa.
**Correlation is significant at the .01 level. 
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4  | DISCUSSION
A number of methods used to quantify protamination and DNA 
packaging, DNA fragmentation, chromosome aneuploidy and mo‐
lecular karyotyping have been applied in the evaluation of male 
infertility problems (Ferlin & Foresta, 2014; Patassini et al., 2013; 
Tsuribe et al., 2016).
The present study was conducted to determine the sperm chro‐
matin condensation (CMA3), the DNA integrity by a TUNEL test, the 
protamine (P1 and P2) concentrations and their ratio in spermatozoa 
from fertile and sub‐fertile male patients using electrophoresis and 
to find out if there was a correlation between protamine deficiency, 
sperm DNA injury and the P1/P2 ratio. A final aim was to investigate 
whether the protamine ratio could be effectively used as an addi‐
tional biomarker test to predict the quality of sperm at the level of 
molecular biology.
The anomalies of spermatozoa protamination make the sperm 
DNA sensitive to oxidative stress (Ozmen, Koutlaki, Youssry, 
Diedrich, & Al‐Hasani, 2007), suggesting that any default in prota‐
mination can induce an injury in the DNA (Aoki, Emery, et al., 2006; 
Aoki, Liu, & Carrell, 2006; Carrell, Emery, & Hammoud, 2007; Nasr‐
Esfahani, Razavi, Mozdarani, Mardani, & Azvagi, 2004; Tarozzi et al., 
2009; Torregrosa et al., 2006). Consequently, the deficiency in pro‐
tamine occurs during the last phases of spermatogenesis, making the 
sperm DNA susceptible to injury and fragmentation and thus lead to 
male	infertility	(Jodar	&	Oliva,	2014).
Sperm DNA first becomes susceptible to damage when the chro‐
matin packing is not fully completed during spermatogenesis (prota‐
mine replacement is occurring in elongating spermatids). Temporary 
nicks, linked to the topoisomerase's activity, facilitate histone–pro‐
tamine replacement but if these nicks are not repaired, the DNA of 
mature	spermatozoa	will	be	fragmented	(Smith	&	Haaf,	1998).
Single‐stranded breaks are produced mainly due to reactive 
oxygen species (ROS; Agarwal & Prabakaran, 2005; Enciso, Sarasa, 
Agarwal, Fernández, & Gosálvez, 2009; Ribas‐Maynou et al., 2012), 
which may come from exogenous sources, such as environmental 
toxicants, smoking, alcohol, diet, radiation and/or from endogenous 
sources, such as an increase in leucocytes, the presence of varico‐
cele or even ROS generated by mitochondria for the movement of 
sperm cells (Agarwal, Virk, Ong, & Plessis, 2014; Aitken & De Iuliis, 
2009; Sakkas & Alvarez, 2010).
In addition, the sperm DNA of males experiencing fertility prob‐
lems can arise through an abortive apoptotic pathway. In this case, 
spermatozoa will lose their capacity to undergo programmed cell 
death in the form of apoptosis because they are transcriptionally 
and translationally inert. But it is thought that this will lead to DNA 
fragmentation in the nucleus of spermatids, which retains the ability 
to metamorphose into mature spermatozoa that probably still have 
the ability to fertilise the oocyte (Sakkas et al., 2004).
Approximately 60% of sperm DNA alterations were clarified by 
the quality of the transition histone–protamine mechanism (Aitken 
& De Iuliis, 2007). The mean percentage of premature chromatin 
condensation in the sperm DNA was demonstrated to be greater in 
the samples presenting a strong protamine deficiency, compared to 
samples with low CMA3‐positive values (Nasr‐Esfahani, Salehi, et al., 
2004).
In addition, the packaging of the sperm chromatin correlated 
with the presence of alterations at the DNA level, a decrease in the 
capability of spermatozoa to penetrate the oocyte and chromatin 
decondensation after fertilisation (Esterhuizen et al., 2002; Razavi, 
Nasr‐Esfahani, Mardani, Mafi, & Moghdam, 2003).
A correlation between protamine deficiency, alterations in DNA 
and the absence of sperm vitality was detected with the help of 
many techniques. To assess the sperm chromatin structure, chro‐
matin structural probes or dyes were used such as chromomycin α 
(competing with protamine binding to DNA, it reveals protamination 
defects on spermatozoa), the acridine orange (measures the suscep‐
tibility to conformational changes), the toluidine blue (that stains 
Parameters
Condensed chromatin 
(n = 133; M ± SD)
Noncondensed chromatin 
(n = 139; M ± SD) p‐value
Age (years) 34.85	±	7.07 32.26 ± 7.43 .004** 
Sperm concentration (106 
sperm/ml)
68.38	±	39.65 61.37 ± 39.52 .146
Progressive motility (%) 38.92	±	19.92 33.01 ± 16.90 .009** 
Normal morphology (%) 23.59 ± 20.31 35.46	±	24.83 .001** 
Sperm DNA fragmenta‐
tion (SDF; %)
14.55 ± 7.04 14.66	±	9.86 .918
Protamine deficiency 
(CMA3) positive (%)
21.69 ± 5.96 46.36 ± 12.95 .0001** 
Protamine 1 (ng/106 spz) 449.80	±	123.97 415.66 ± 122.44 .023
Protamine 2 (ng/106 spz) 405.00 ± 125.90 391.03 ± 124.60 .359
P1/P2 ratio 1.00 ± 0.32 0.66 ± 0.47 .001** 
Abbreviations: M, mean; SD, standard deviation; Spz, spermatozoa.
**Correlation is significant at the .01 level. 
TA B L E  5   Comparison of studied 
parameters between the two groups 
condensed chromatin and not condensed 
chromatin (CMA3 test)
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phosphate residues of fragmented DNA) and the aniline blue (that 
stains loosely condensed chromatin; Evenson & Wixon, 2006).
Moreover, different techniques are used to assess the DNA frag‐
mentation. The commonly used techniques are terminal deoxynu‐
cleotidyl transferase mediated dUDP nick‐end labelling (TUNEL), 
the sperm chromatin dispersion (SCD) assay and the comet assay 
(Agarwal et al., 2016). Each assay purportedly measures different 
forms of DNA damage.
Unfortunately, most of the available techniques provide limited 
information regarding the nature of the DNA lesions and do not 
allow the exact pathogenesis of disrupted sperm DNA to be high‐
lighted (Agarwal & Said, 2004; Bungum, 2012). For example, chro‐
momycin A3 (CMA3), a guanine‐cytosine‐specific fluorochrome 
competes with protamine for binding to the minor groove of DNA 
(Bianchi et al., 1993; Sakkas et al., 1996). Since the protamines are 
not directly examined, this approach still does not fully answer the 
question, namely: What the real cause of increased staining may 
be? However, CMA3 can be used as a feasible indicator and the in‐
creased stainability presents a general description about the anom‐
alies in the chromatin packaging of spermatozoa, leading to DNA 
damage or other problems in the spermatozoa.
The literature concerning sperm DNA decays and sperm pa‐
rameters and/or clinical outcomes is controversial. There is no clear 
correlation between sperm morphology assisted by strict criteria, 
sperm count and chromatin condensation (Berkovitz et al., 2005; 
Hazout,	Dumont‐Hassan,	Junca,	Bacrie,	&	Tesarik,	2006).	A	prospec‐
tive analysis study of semen parameters and sperm chromatin struc‐
ture assay, conducted by Sills, Fryman, Perloe, Michels, and Tucker 
(2004), demonstrated a nonsignificant correlation between DNA 
fragmentation and sperm concentration. Furthermore, the sperm 
DNA apoptosis rates were significantly higher in patients with ab‐
normal sperm parameters compared to patients with normal sper‐
matozoa (Huang et al., 2005).
In patients with unexplained recurrent pregnancy loss, aneu‐
ploidy, abnormal morphology and the apoptosis rate were signifi‐
cantly correlated (Carrell et al., 2003).
Cohen‐Bacrie et al. (2009) examined in a study of more than 
1,600 couples to evaluate the correlation between the semen pa‐
rameters, including CASA and the fragmentation rates (TUNEL) and 
stated that sperm parameters and DNA damage were complemen‐
tary rather than strongly linked.
In a large meta‐analysis (43 studies), researchers concluded that 
SDF decreases pregnancy rates when conventional IVF or ICSI are 
used (Simon, Zini, Dyachenko, Ciampi, & Carrell, 2017).
Moreover, a number of studies demonstrated a significant posi‐
tive correlation between the sperm DNA damage and age, and sug‐
gested that men under 35 years old had a lower DNA fragmentation 
rate (Belloc et al., 2009; Vagnini et al., 2007) and that a decrease 
in fertilisation, embryo quality, implantation and pregnancy rates 
(Johnson	et	al.,	2015).	However,	other	studies	 reported	contradic‐
tory findings suggesting that neither the standard semen parameters 
and the sperm DNA fragmentation nor the fertilisation is affected by 
male age (Nijs et al., 2011; Winkle, Rosenbusch, Gagsteiger, Paiss, & 
Zoller, 2009). Tapia et al. (2017) reported that there is no difference 
in fertilisation or pregnancy rates when young eggs were insemi‐
nated with an old spermatozoon.
Many studies, on the other hand, have demonstrated that 
sperm DNA damage correlates negatively with fertilisation, cleav‐
age, implantation and the pregnancy rate (Agarwal & Prabakaran, 
2005; Benchaib et al., 2003; Host, Lindenberg, & Smidt‐jensen, 
2000).
The functional implications of the sperm DNA are still not clear. 
This is because the fragmentation of the DNA can be the conse‐
quence of (a) intrinsic factors, such as abortive apoptosis, the anom‐
alies of the recombination and the imbalances of the protamine 
(P1/P2 ratio) or oxidative stress or (b) external factors, such as the 
storage temperatures or the cryopreservation (González‐Marín, 
Gosálvez, & Roy, 2012).
Reactive oxygen species and oxidative damage can be a major 
cause of declining sperm quality; antioxidants can be important in 
preventing this (Ahmadi, Bashiri, Ghadiri‐Anari, & Nadjarzadeh, 
2016).
TA B L E  6   Comparison of studied parameters between the three groups obtained following the results of the TUNEL test
Parameters
Nonfragmented DNA 
(n = 133; M ± SD)
Moderate fragmented 
DNA (n = 19; M ± SD)
Fragmented DNA 
(n = 93; M ± SD) p‐value
Age (year) 32.55 ± 7.05 34.14	±	6.81 38.37	±	10.19 .003** 
Sperm concentration (×106 spz/ml) 70.12 ± 40.51 61.59 ± 37.29 37.42 ± 32.12 .002** 
Progressive motility (%) 40.85	±	19.14 29.96 ± 15.49 25.58	±	16.75 .001** 
Normal morphology (%) 28.35	±	20.60 29.80	±	24.74 39.58	±	35.31 .143
Sperm DNA fragmentation (SDF; %) 8.77	±	3.31 20.01 ± 3.33 34.88	±	8.25 .001** 
Protamine deficiency (CMA3 positive; %) 34.11 ± 16.177 33.62 ± 15.191 39.32	±	18.160 .356
Protamine 1 (ng/106 spz) 443.69 ± 122.04 408.67	±	124.66 460.09 ± 126.19 .055
Protamine 2 (ng/106 spz) 415.66	±	118.74 367.92	±	128.55 404.45 ± 137.04 .012* 
(P1/P2) ratio 0.69 ± 0.43 0.97 ± 0.39 1.16 ± 0.23 .001** 
Abbreviations: M, Mean; SD, standard deviation; Spz, spermatozoa.
*Correlation is significant at the .05 level. 
**Correlation is significant at the .01 level. 
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Despite the high incidence of defective sperm function, very few 
reliable therapies are available. This could be explained by the gen‐
eral lack of knowledge concerning the precise biochemical nature 
of the cause of such sperm defects. In fact, there is little reliable 
information concerning the factors that are causing the fertilising 
capacity loss of spermatozoa.
The Cochrane review suggested that the use of antioxidants 
caused	a	1.8‐	to	4.6‐fold	increase	in	the	chances	of	achieving	a	nat‐
ural pregnancy. However, up to a 6.5‐fold increase in miscarriages 
might also be observed (Showell et al., 2014). In ICSI therapy, it is still 
not obvious if antioxidant use may be effective or not in improving 
pregnancy results and birth rates (Agarwal et al., 2014; Tremellen, 
Miari, Froiland, & Thompson, 2007).
Evaluations of abnormal chromatin condensation by CMA3 
staining and of the DNA fragmentation by TUNEL have been used 
in this study.
In the current study, the deficiency in protamine (CMA3), de‐
termined by the CMA3 test, correlated negatively with the sperm 
concentration (r	=	−.172,	p < .01). However, no correlation has been 
found either with the motility or with the DNA fragmentation (SDF; 
Table 2). By dividing all the investigated samples according to the 
CMA3	test	results	(CMA3	≤	31%;	CMA3	>	31%),	in	the	group	of	non‐
condensed DNA (CMA3 > 31%) the progressive mobility was signifi‐
cantly lower (p = .009), compared to the group of condensed DNA 
(CMA3	≤	31%)	but	 there	was	no	significant	difference	 in	 the	SDF,	
P1 and P2 values in both of the investigated groups, whereas in the 
noncondensed DNA group (CMA3 > 31%), the P1/P2 ratio was sig‐
nificantly lower (p = .001; Table 5).
These findings are partly in agreement with the results of Tarozzi 
et al. (2009), who found that protamine deficiency (CMA3 positive) 
correlated negatively (p < .05) with concentration, motility and nor‐
mal morphology.
Moreover, Iranpour (2014) found that the CMA3 positive and the 
morphologically abnormal spermatozoa showed a positive correla‐
tion (r = .461, p < .001), but CMA3 positive correlated negatively 
with the sperm count and motility (r	 =	 −.359,	 p < .001; r	 =	 −.37,	
p < .001 respectively).
The alterations in protamination may be a possible cause of the 
decrease in the spermatozoa function. In fact, Carrell et al. (2007) 
interestingly posed two main hypotheses concerning this subject: 
firstly, the protamine can act as a “control” during the spermatogen‐
esis and the aberrant expression of the protamine can increase the 
apoptosis level, which then causes a decrease in the quality of sper‐
matozoa; secondly, the aberrant protamine expression can be the 
sign of an altered spermatogenesis during the transcription and/or 
translation regulation.
Moreover, it has been demonstrated that the SDF was a good 
predictive marker for a successful pregnancy in ART (Larson‐Cook 
et al., 2003).
In the present study, by comparing the groups subdivided ac‐
cording	to	the	SDF	value	 (SDF	≤	15%;	16%–30%;	SDF	≥	30%),	 it	
was shown that the age was higher (p = .03) in the fragmented 
DNA group, but the concentration and the progressive motility 
were significantly greater (p < .01) in the nonfragmented DNA 
group, while morphology and CMA3 positive were similar in both 
groups (Table 6).
The SDF also correlated positively with the age (r = .199; p = .001) 
but negatively with the sperm count (r	=	−.201;	p = .001) and the mo‐
tility (r	=	−.334;	p = 0; Table 2a).
These results from our study demonstrate the absence of any 
relationship between protamine deficiency in spermatozoa, and al‐
terations of sperm DNA (Tables 4, 5 and 6) and are therefore contra‐
dictory to previous studies which demonstrated that the deficiency 
of protamine and the DNA fragmentation were positively correlated 
(García‐Peiró et al., 2011; Ni et al., 2014; Nili, Mozdarani, & Aleyasin, 
2009).
However, the absence of any correlation between the DNA le‐
sions and the deficiency of protamine can be explained by the fact 
that several other factors, such as the oxidative stress, can lead to a 
fragmented DNA.
It is therefore probable that absolute or relative protamine 
deficiency can be a cause of defective chromatin compaction 
(Aravindan, Krishnamurthy, & Moudgal, 1997) and increase suscep‐
tibility to DNA damage (Aoki, Emery, et al., 2006; Aoki, Moskovtsev, 
et al., 2005), suggesting that sperm DNA damage may be partly due 
to a defect in spermiogenesis during the histone–protamine transi‐
tion (Steger, Pauls, Klonisch, Franke, & Bergmann, 2000).
Abnormities in sperm chromatin packaging are associated with 
the poor fertility of human spermatozoa (Aoki, Moskovtsev, et al., 
2005). Protamine deficiency is associated with a decrease in the 
fertilising ability of spermatozoa and the quality of human embryos 
(Aoki, Moskovtsev, et al., 2005; Balhorn et al., 1999; Carrell & Liu, 
2001;	de	Yebra	et	al.,	1998).
Nevertheless, the protamine values P1 and P2 correlated signifi‐
cantly with the SDF in both investigated groups (Tables 3 and 4) and 
the protamine (P1 and P2) concentrations were significantly lower 
(p < .05) in the group of sub‐fertile subjects in comparison with the 
fertile one whereas the protamine ratio (P1/P2) was significantly 
greater (p = .003) in the sub‐fertile group (Table 1).
The protamine ratio (P1/P2), in turn, had a positive relation‐
ship with the SDF in both groups (r = .365; p = .001; and r = .479; 
p = .001 respectively) but correlated negatively with CMA3 positive 
(r	=	−.586;	p = .001) in the fertile group (Table 3).
These findings were in accordance with various other studies con‐
firming a correlation between the anomalies of the protamine ratio and 
infertility (De Mateo et al., 2009; Ni et al., 2014). Ni, Spiess, Schuppe, 
and Steger (2016) confirmed that the protamine ratio was lower in the 
fertile group in comparison with the ratio in the sub‐fertile group.
In humans, P1 and P2 are expressed in nearly equal quantities, 
with the P1/P2 ratio close to 1, and alterations of the protamine 
ratio in either direction are associated with a decrease in sperm pa‐
rameters (Aoki, Emery, et al., 2006).
While an altered protamine ratio has never been observed in 
fertile men (Carrell & Liu, 2001; Oliva, 2006), an abnormal P1/P2 
ratio is associated with a low sperm count, reduced motility, abnor‐
mal head morphology, a higher frequency of DNA fragmentation and 
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a lower sperm penetration assay score (Aoki, Liu, & Carrell, 2005; 
Aoki, Moskovtsev, et al., 2005). Decreased clinical‐pregnancy rates 
have been associated with spermatozoa having a reduced P1/P2 
ratio (Aoki, Emery, et al., 2006).
In general, classic sperm parameters are not providing sufficient 
details about the quality and the function of sperm; this is why an 
assessment of the protamine ratio is useful for an assessment of 
spermatozoon.
It was shown that the P1 value and CMA3 positive did not dif‐
fer significantly between the three groups, divided according to SDF 
value, whereas the P2 value was obviously greater in the nonfrag‐
mented	DNA	group	 (SDF	≤	15%;	p = .012; Table 6). Nevertheless, 
the protamine ratio was significantly lower in the group with non‐
fragmented DNA and high among the group with fragmented 
DNA (p = .001). These results are in agreement with other findings 
(Castillo, Simon, Mateo, Lewis, & Oliva, 2011; Hammadeh et al., 
2010) that demonstrated a positive relationship between the pres‐
ence of the precursors of protamine 2 or the alteration of the prota‐
mine ratio and the damaged DNA.
Ni et al. (2016) analysed 12 studies and found that protamine 
deficiency (CMA3 assay) correlated significantly with the DNA frag‐
mentation of spermatozoa while the protamine ratio had no associa‐
tion with the DNA fragmentation.
This is the first study to demonstrate that the protamine ratio 
(P1/P2) correlated positively with SDF among all the investigated 
groups but negatively with chromatin deficiency (CMA3 positive).
5  | CONCLUSION
DNA integrity in spermatozoa is strictly linked to protamine defi‐
ciency. However, DNA fragmentation is linked to the protamine ratio 
instead of CMA3. This finding supports the assumption that prota‐
mines are implicated in DNA preservation. As a result, the protamine 
ratio (P1/P2) may indeed be used as a good biomarker for the assess‐
ment of sperm DNA.
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